LOLLINI ROBERT J 4
4 · Myriad Pharmaceuticals, Inc. · Filed Feb 22, 2010
Insider Transaction Report
Form 4
LOLLINI ROBERT J
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2010-02-18+33,000→ 33,000 totalExercise: $4.83Exp: 2020-02-18→ Common Stock (33,000 underlying)
Footnotes (1)
- [F1]The option vests over a four-year period as to one quarter of the shares on each anniversary of the date of grant.